- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 1 x KNH: Myxovirescin A(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 8 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.4: 2 residues within 4Å:- Chain A: I.35
- Ligands: OLC.9
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.35
OLC.5: 7 residues within 4Å:- Chain A: G.32, T.33, L.36, I.37, F.40
- Ligands: OLC.6, SO4.15
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.36, A:I.37, A:F.40
- Hydrogen bonds: A:T.33
OLC.6: 6 residues within 4Å:- Chain A: F.30, T.33
- Ligands: OLC.5, OLC.7, SO4.15, SO4.17
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:T.33
OLC.7: 3 residues within 4Å:- Chain A: L.114
- Ligands: OLC.6, SO4.17
No protein-ligand interaction detected (PLIP)OLC.8: 4 residues within 4Å:- Chain A: I.94, F.105, D.109
- Ligands: OLC.11
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.94
- Hydrogen bonds: A:D.109
OLC.9: 8 residues within 4Å:- Chain A: Y.29, I.31, S.34, A.38, F.106, S.121, F.124
- Ligands: OLC.4
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.38, A:F.106, A:F.106, A:F.106, A:F.124, A:F.124
OLC.10: 8 residues within 4Å:- Chain A: I.98, L.102, F.105, D.109, L.163, I.170
- Ligands: KNH.1, OLC.11
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.98, A:L.102, A:F.105, A:F.105, A:L.163
OLC.11: 3 residues within 4Å:- Chain A: F.105
- Ligands: OLC.8, OLC.10
No protein-ligand interaction detected (PLIP)- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.15: 7 residues within 4Å:- Chain A: K.27, F.30, I.31, G.32, T.33
- Ligands: OLC.5, OLC.6
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.32, A:T.33, A:T.33, A:T.33
- Salt bridges: A:K.27
SO4.16: 4 residues within 4Å:- Chain A: G.86, K.87, M.88, T.89
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:M.88, A:T.89
SO4.17: 6 residues within 4Å:- Chain A: M.25, H.26, K.27, F.30
- Ligands: OLC.6, OLC.7
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:M.25, A:K.27
- Salt bridges: A:H.26, A:K.27
SO4.18: 3 residues within 4Å:- Chain A: K.27, K.28, Y.29
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.28, A:Y.29
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olatunji, S. et al., Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin. Nat Commun (2020)
- Release Date
- 2020-01-15
- Peptides
- Lipoprotein signal peptidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- monomer
- Ligands
- 1 x KNH: Myxovirescin A(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- 8 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olatunji, S. et al., Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin. Nat Commun (2020)
- Release Date
- 2020-01-15
- Peptides
- Lipoprotein signal peptidase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.